ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Virtualware 2007 SA

Virtualware 2007 SA (MLVIR)

8.40
0.00
(0.00%)
Closed 12 January 3:30AM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
8.40
Bid
7.40
Offer
7.35
Volume
0.00
0.00 Day's Range 0.00
7.20 52 Week Range 8.45
Market Cap
Previous Close
8.40
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
1
Shares Outstanding
4,542,000
Dividend Yield
-
PE Ratio
2,545.45
Earnings Per Share (EPS)
-
Revenue
5.05M
Net Profit
15k

About Virtualware 2007 SA

Sector
Hardware-wholesale
Industry
Hardware-wholesale
Headquarters
Bilbao, Basque Country, Esp
Founded
-
Virtualware 2007 SA is listed in the Hardware-wholesale sector of the Euronext with ticker MLVIR. The last closing price for Virtualware 2007 was 8.40 €. Over the last year, Virtualware 2007 shares have traded in a share price range of 7.20 € to 8.45 €.

Virtualware 2007 currently has 4,542,000 shares in issue. The market capitalisation of Virtualware 2007 is 38.15 € million. Virtualware 2007 has a price to earnings ratio (PE ratio) of 2545.45.

MLVIR Latest News

Virtualware Canada joins forces with Invest WindsorEssex and NextStar Energy in $3.8 million battery manufacturing training program

Virtualware Canada joins forces with Invest WindsorEssex and NextStar Energy in $3.8 million battery manufacturing training program Ontario, Toronto, December 12, 2024 – The leading expert in...

Virtualware announces VIROO integration with HTC VIVE’s VIVERSE Polygon Streaming technology at I/ITSEC 2024

Orlando, December 5, 2024 – The leading expert in 3D-driven enterprise software as a service Virtualware (EPA: MLVIR), announced the integration of its XR platform VIROO with HTC VIVE’s VIVERSE...

Virtualware Acquires Sweden's Simumatik to Strengthen Position in the Real-Time 3D Enterprise Software Industry

Virtualware Acquires Sweden's Simumatik to Strengthen Position in the Real-Time 3D Enterprise Software Industry Bilbao, October 21, 2024.— Spanish-listed company Virtualware (EPA:MLVIR), a...

HTC VIVE and Virtualware partner to accelerate adoption of enterprise XR

HTC VIVE and Virtualware partner to accelerate adoption of enterprise XR Orlando, Florida, October 7, 2024.- Global leader in premium XR solutions HTC VIVE and European XR enterprise software and...

Litchfield Hills Research raises its buy recommendation for Virtualware to €12 per share

Litchfield Hills Research raises its buy recommendation for Virtualware to €12 per share New York and Bilbao, Spain, 24 September. - American equity research firm Litchfield Hills Research has...

Virtualware unveils VIROO 2.6, the latest evolution of its enterprise XR platform with updates to the publishing workflow and interoperability

BILBAO, September 19, 2024 – The leading expert in 3D-driven enterprise software as a service Virtualware (EPA: MLVIR), announced today the release of version 2.6 of its XRaaS platform, VIROO...

Virtualware reports revenues of €2.034 million and net profit of €199,164 in 1H2024

Virtualware reports revenues of €2.034 million and net profit of €199,164 in 1H2024 BILBAO, Spain, July 18.- European Virtual Reality company Virtualware recorded revenues of €2.034 million in the...

Virtualware partners with MACE Virtual Labs to support US market growth for enterprise VR solutions

Virtualware partners with MACE Virtual Labs to support US market growth for enterprise VR solutions BILBAO, Spain, June 13, 2024, Virtualware (EPA: MLVIR), the European leader in enterprise...

Virtualware Partners with AXXIST to Strengthen VIROO's Presence in Latin America

Virtualware Partners with AXXIST to Strengthen VIROO's Presence in Latin America Bilbao, Spain, Brazil 4 June 2024.- Virtualware (EPA: MLVIR), the European leader in virtual reality, has...

Litchfield Hills Research reiterates buy recommendation at $10.00 per share

Litchfield Hills Research reiterates buy recommendation at $10.00 per share New York and Bilbao, Spain, 21 May - US equity research firm Litchfield Hills Research has just published a new...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1008.48.48.400DE
4008.48.48.418.4DE
12008.48.48.418.4DE
26008.48.48.408.4DE
520.9127.58.457.2167.65662935DE
1561.929.23076923086.58.556357.52927119DE
2601.929.23076923086.58.556357.52927119DE

MLVIR - Frequently Asked Questions (FAQ)

What is the current Virtualware 2007 share price?
The current share price of Virtualware 2007 is 8.40 €
How many Virtualware 2007 shares are in issue?
Virtualware 2007 has 4,542,000 shares in issue
What is the market cap of Virtualware 2007?
The market capitalisation of Virtualware 2007 is EUR 38.15M
What is the 1 year trading range for Virtualware 2007 share price?
Virtualware 2007 has traded in the range of 7.20 € to 8.45 € during the past year
What is the PE ratio of Virtualware 2007?
The price to earnings ratio of Virtualware 2007 is 2.55k
What is the cash to sales ratio of Virtualware 2007?
The cash to sales ratio of Virtualware 2007 is 7.55
What is the reporting currency for Virtualware 2007?
Virtualware 2007 reports financial results in EUR
What is the latest annual turnover for Virtualware 2007?
The latest annual turnover of Virtualware 2007 is EUR 5.05M
What is the latest annual profit for Virtualware 2007?
The latest annual profit of Virtualware 2007 is EUR 15k
What is the registered address of Virtualware 2007?
The registered address for Virtualware 2007 is USAUSUAGA N�� 7, 48970, BASAURI, BILBAO, BASQUE COUNTRY, 28046
What is the Virtualware 2007 website address?
The website address for Virtualware 2007 is www.virtualwareco.com
Which industry sector does Virtualware 2007 operate in?
Virtualware 2007 operates in the HARDWARE-WHOLESALE sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MLCOTCoretech 5
0.012 €
(140.00%)
90.21k
ALCABCabasse SA
0.72 €
(41.18%)
16.96k
ALAGOEPango SA
0.1828 €
(21.87%)
9.37M
LEBLLcx Leblanc Chr
0.356 €
(18.67%)
4
ALALOAcheterLouerFR
0.11 €
(15.55%)
73.87k
BNBSTonner Drones
0.001 €
(-50.00%)
23.99k
DBVDBV Technologies
0.875 €
(-23.91%)
4.89M
MLCOUCourbet
1.75 €
(-15.87%)
51
MLAZRThe Azur Selection SA
1.00 €
(-15.25%)
130.18k
PROACProactis SA
0.0565 €
(-13.74%)
560
ATOAtos SE
0.002 €
(0.00%)
1.75B
BCPBanco Comercial Portugues SA
0.4802 €
(0.04%)
53.25M
ALCYBCybergun
0.0001 €
(0.00%)
20.24M
EDPEDP SA
2.974 €
(-4.77%)
15.95M
ALVERVergnet
0.0018 €
(0.00%)
15.63M

Discussion

View Full Feed
dstock07734 dstock07734 1 minute ago
Gary,

I strongly suggest you go through the details of all the outcome measures adopted in the combo trial. They are so disruptive. I also think we should abandon the old concept about the definition of phase on clinical trials. The phase definition for DCVax-L doesn't matter. What it
NWBO
manibiotech manibiotech 2 minutes ago
Yep you did get it straight .
There is a reason companies apply to FDA and EMA . And there is reason for current SP.
But problem is that when given  straight to you , you can't comprehend straightforward reasons 
NWBO
Lime Time Lime Time 3 minutes ago
Very good opportunity
GVSI
gshores gshores 7 minutes ago
Nothing personal, but you reek of desperation for some reason. Longs will do great here.
SPZI
jondoeuk jondoeuk 8 minutes ago
Data from the PhII 2-THE-TOP trial https://www.onclive.com/view/temozolomide-pembrolizumab-plus-ttfields-leads-to-tumor-control-in-newly-diagnosed-glioblastoma
NVCR
kBletsgo30 kBletsgo30 9 minutes ago
Yeah right 
RSPI
ddls ddls 9 minutes ago
Maybe you should double down, buy 10M shares...😎

Just watch out for these types of days..."1/3/25, Buy: 1,300,000, Neutral: 366,005, Sell: 66,963,117.😎

You'll be seeing more of them.
BIEL
XMaster2023 XMaster2023 13 minutes ago
I would take your bet but you have the ethics of someone who would work for an idiot who would try to kill a cure for cancer. Thus, I would never trust you!
NWBO
manibiotech manibiotech 15 minutes ago
And someone to pay NWBO ( not advent ) for those treatments 
NWBO
StockItOut StockItOut 18 minutes ago
Are they really? That's evidence of a scam.
XERI
skitahoe skitahoe 18 minutes ago
Dstocks, it's clear that many are interested in the kind of work we're doing. My question is, are any beyond the Phase 1/2 trials.

I believe we're clearly the leaders here and with approvals while it may make it easier for others, they'll still be many years before the can possibly g
NWBO
vinmantoo vinmantoo 20 minutes ago
Have you seen the stock price?

Enough said.

The stock price alone certainly isn't enough said.
Eagle1 Eagle1 23 minutes ago
SDCRBS, Please let me know if I can help you in any way. Just DM me. I'm sorry and sad to see all this CA and LA destruction.

I'm in the Houston area and couldn't imagine this type of destruction.

So Sorry.
GDVM
Plasmode Plasmode 27 minutes ago
I’ve learned so much from valuable contributors like Mr C and Dino and great respects for your researches and insights, then this kind of bickering just knock you off the pedestal into muck. Just respond with ‘next’ if you refuse to lower yourself into the mud. I have more respect for people like
TGLO
elks elks 28 minutes ago
Tic toc
GVSI
jondoeuk jondoeuk 30 minutes ago
Translational data from the PhI B-cell lymphomas trial demonstrated primary, secondary and tertiary tissue trafficking and clearance of CD19+ cells. That should help enable an immune reset in autoimmune diseases.

The next-gen CAR-T's will incorporate a suite of novel synthetic edits t
FATE
elks elks 31 minutes ago
Agreed
HMBL
gimmee greenbacks gimmee greenbacks 32 minutes ago
Testify 3331!

Biel Gonna. R U N in 2025!!!!!!




BIEL
BIEL
Dieselsmoke Dieselsmoke 33 minutes ago
Let her fly
RGTI
KevGee59 KevGee59 37 minutes ago
Epstein...Diddy...nuff said ;)
NWBO
dinogreeves dinogreeves 38 minutes ago
Good night Slojab and good luck.
TWOH
KevGee59 KevGee59 39 minutes ago
The trees love it!
NWBO
Slojab Slojab 40 minutes ago
If everyone could just remain patient, we'll probably have an answer to what's going on next week.

Good night.
TWOH
TRAPPER JIM TRAPPER JIM 41 minutes ago
Sounds good. I'll probably go to the grocery store tomorrow for a few things.  Looking for some simple cabinets at Lowe's now. I need to hang a couple cabinets over my workbench out in the garage 
Slojab Slojab 43 minutes ago
Since the reason for the halt is unknown, I can't say for sure what the ultimate resolution will be. A suspension however is probably very low on the list of possible outcomes.
TWOH